SCHEMBL4596961

SCHEMBL4596961

O=C(O)[C@@H](Cc1ccccc1)N1C(=O)CNC1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
PKM P14618 1/20 0.68
GAA P10253 1/20 0.59
KMT2A Q03164 4/20 0.54
AADAT Q8N5Z0 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.53
TSHR P16473 1/20 0.52
HSD17B10 Q99714 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
POLB P06746 4/20 0.50
MAPT P10636 3/20 0.49
MEN1 O00255 2/20 0.49
LMNA P02545 1/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
PTPN7 P35236 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4596965 1.00 ALDH1A1 (0.68) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL4597073 1.00 ALDH1A1 (0.68) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL1134045 0.87 ALDH1A1 (0.62) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL1563867 0.81 ALDH1A1 (1.00) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL2304471 0.81 ALDH1A1 (1.00) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL6386661 0.80 ALDH1A1 (0.90) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL7334247 0.78 ALDH1A1 (0.77) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL10536673 0.76 ALDH1A1 (0.68) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL9326774 0.76 ALDH1A1 (0.68) ALDH1A1PKMGAAKMT2AAADAT
SCHEMBL8873673 0.76 ALDH1A1 (0.68) ALDH1A1PKMGAAKMT2AAADAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506177-B1 PROCESS FOR THE PREPARATION OF THE ENANTIOMERIC FORMS OF 2-SUBSTITUTED 2-(2,5-DIOXOIMIDAZOLIDIN-1-YL)-ACETIC ACID DERIVATIVES SANOFI AVENTIS DEUTSCHLAND (DE) 2008-01-16 EP disclosed
US-6908752-B2 Process for the preparation of the enant iomeric forms of 2-substituted 2- (2, 5-dioxoimidazolidin-1yl) -acetic acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-06-21 US disclosed
US-20030054507-A1 Process for the preparation of the enant iomeric forms of 2-substituted 2- (2, 5-dioxoimidazolidin-1-yl) -acetic acid derivatives SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2003-03-20 US disclosed